Skip to main content
Premium Trial:

Request an Annual Quote

Michigan Taps Orchid Cellmark for Paternity Testing

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark will provide its DNA paternity testing services to the State of Michigan under a new contract valued at around $5.2 million, the company said today.

The firm said that the contract enables it to provide its services to the Michigan Department of Human Services' Office of Child Support and the Children's Protective Services.

The contract from the Michigan Department of Management and Budget makes the company the sole provider of all publicly funded DNA paternity tests in the state between April 2010 and March 2015, the company said.

In early Tuesday trade on the Nasdaq, shares of Orchid Cellmark were up 6 percent at $1.50.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.